|
|
 |
| |
|
Home > Drug Companies > Cephelon, Inc.
Cephelon, Inc.
In 1987, a small team of pioneering young researchers launched Cephalon with the vision of building an integrated biopharmaceutical company with a presence in major markets around the world. Today, Cephalon is poised for a new level of growth, with an expanded international presence, a diverse product portfolio, and drugs with even greater therapeutic potential. From researching target molecules to advancing late-stage compounds, Cephalon is contributing to scientific understanding while preparing a new portfolio of therapies that promise to have a profound impact on human health. They constantly seek ways to advance their company and the industry to an ever more flexible and responsive approach to drug development.
Cephalon is one of the world's fastest-growing biopharmaceutical companies. They are driven by their mission to deliver industry-leading growth by achieving the most efficient and sustainable means of delivering new value to the marketplace. Cephalon specializes in drugs to treat and manage neurological diseases, sleep disorders, cancer and pain. They employ more than 2,300 people worldwide with operations in the United States and Europe.
Key US sites include their corporate headquarters in Frazer, Pennsylvania, research and development in West Chester, Pennsylvania and Brooklyn Park, Minnesota, and manufacturing facilities in Salt Lake City, Utah and Eden Prairie, Minnesota. Key European sites include offices in Guildford, England; Martinsried, Germany; and Maisons-Alfort, France.
Cephalon leverages its business insight and R&D initiative to unlock the promise of biotechnology and to deliver the treatments that improve human life. By building a strong and sustainable business, they increase the opportunities to create medical breakthroughs.
As a successful biopharmaceutical company, they believe in sharing their success with their neighbors and employees and in helping to build strong communities through charitable giving. Good business allows Cephalon to support and discover good medicine, and enables them to partner with communities by making grants primarily to qualified not for profit organizations through their Corporate Contributions Program.
Streamlined and agile, their organization is second to none. Cephalon attracts leading talent and fosters a culture founded on teamwork and respect. And readily embraces the most advanced research and clinical development techniques. Cephalon employs hundreds of leading scientists who communicate and work across multiple disciplines, geographies and areas of expertise.
Back to Drug Companies
|
|
|
|
|
|
|
|